Tectonic Therapeutic, Inc. (TECX)
NASDAQ: TECX · Real-Time Price · USD
21.04
+0.39 (1.89%)
Oct 19, 2026, 9:51 AM EDT - Market open
Tectonic Therapeutic Employees
Tectonic Therapeutic had 60 employees as of December 31, 2025. The number of employees increased by 9 or 17.65% compared to the previous year. That makes Tectonic Therapeutic the 34,148th largest employer in the world and 4,530th in the United States.
Employees
60
Change (1Y)
9
Growth (1Y)
17.65%
Revenue / Employee
n/a
Profits / Employee
-$1,429,783
Market Cap
411.32M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 60 | 9 | 17.65% |
| Dec 31, 2024 | 51 | 7 | 15.91% |
| Mar 31, 2024 | 45 | - | - |
| Dec 31, 2023 | 44 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| ProKidney | 231 |
| Capricor Therapeutics | 231 |
| ARS Pharmaceuticals | 200 |
| MapLight Therapeutics | 133 |
| Assembly Biosciences | 73 |
| AgomAb Therapeutics NV | 62 |
| Rezolute | 58 |
| Zura Bio | 40 |
TECX News
- 6 days ago - Tectonic Therapeutic Slides: Conference presentation - Filings
- 7 days ago - Tectonic Therapeutic initiated with a Neutral at UBS - TheFly
- 18 days ago - Tectonic Therapeutic Transcript: Stifel 2026 Virtual Cardiometabolic Forum - Transcripts
- 20 days ago - Tectonic Therapeutic announces results from Phase 1a trial of TX2100 - TheFly
- 20 days ago - Tectonic Therapeutic Announces Favorable Phase 1 Safety, Tolerability and PK Results for TX2100, a Novel Approach for the Treatment of Hereditary Hemorrhagic Telangiectasia (HHT) - GlobeNewsWire
- 6 weeks ago - Tectonic Therapeutic to Participate in the Morgan Stanley Global Healthcare Conference - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Announces Second Quarter 2026 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Tectonic Therapeutic Quarterly report: Q2 2026 - Filings